- Home
- BBAI vs ARQT Comparison
BBAI vs ARQT Comparison
Compare BBAI & ARQT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BBAI
- ARQT
- Stock Information
- Founded
- BBAI 2020
- ARQT 2016
- Country
- BBAI United States
- ARQT United States
- Employees
- BBAI N/A
- ARQT N/A
- Industry
- BBAI EDP Services
- ARQT Biotechnology: Pharmaceutical Preparations
- Sector
- BBAI Technology
- ARQT Health Care
- Exchange
- BBAI Nasdaq
- ARQT Nasdaq
- Market Cap
- BBAI 2.2B
- ARQT 1.9B
- IPO Year
- BBAI N/A
- ARQT 2020
- Fundamental
- Price
- BBAI $5.07
- ARQT $17.29
- Analyst Decision
- BBAI Strong Buy
- ARQT Strong Buy
- Analyst Count
- BBAI 3
- ARQT 7
- Target Price
- BBAI $5.83
- ARQT $19.00
- AVG Volume (30 Days)
- BBAI 51.8M
- ARQT 1.5M
- Earning Date
- BBAI 11-04-2025
- ARQT 11-05-2025
- Dividend Yield
- BBAI N/A
- ARQT N/A
- EPS Growth
- BBAI N/A
- ARQT N/A
- EPS
- BBAI N/A
- ARQT N/A
- Revenue
- BBAI $152,561,000.00
- ARQT $263,464,999.00
- Revenue This Year
- BBAI N/A
- ARQT $72.46
- Revenue Next Year
- BBAI $14.20
- ARQT $32.00
- P/E Ratio
- BBAI N/A
- ARQT N/A
- Revenue Growth
- BBAI 3.46
- ARQT 99.50
- 52 Week Low
- BBAI $1.36
- ARQT $8.03
- 52 Week High
- BBAI $10.36
- ARQT $18.15
- Technical
- Relative Strength Index (RSI)
- BBAI 41.64
- ARQT 61.58
- Support Level
- BBAI $4.65
- ARQT $15.13
- Resistance Level
- BBAI $5.06
- ARQT $18.15
- Average True Range (ATR)
- BBAI 0.26
- ARQT 0.66
- MACD
- BBAI 0.02
- ARQT 0.14
- Stochastic Oscillator
- BBAI 49.41
- ARQT 71.80
About BBAI BigBear.ai Inc.
BigBear.ai Holdings Inc is a technology-led solutions organization, that provides both software and services to its customers. Its AI-powered decision intelligence solutions are leveraged in three markets; supply chains & logistics, autonomous systems, and cybersecurity. It operates in two segments; Cyber & Engineering segment and Analytics segment. Company generate revenue by providing customers with Edge AI-powered decision intelligence solutions and services for data ingestion, data enrichment, data processing, artificial intelligence, machine learning, predictive analytics and predictive visualization. It generate revenue from providing both software and services to customers.
About ARQT Arcutis Biotherapeutics Inc.
Arcutis Biotherapeutics Inc is a medical dermatology company. It is developing treatments for patients with immune-mediated dermatological diseases and conditions. It is leveraging recent advances in immunology and inflammation to develop differentiated therapies against biologically validated targets to solve persistent treatment challenges in serious diseases of the skin. The company's product candidate ZORYVE roflumilast cream, has completed pivotal Phase 3 clinical trials in plaque psoriasis, demonstrating symptomatic improvement and favorable tolerability in this population.